Burzynski Research Institute Inc (BZYR) financial statements (2022 and earlier)

Company profile

Business Address 12000 RICHMOND AVE
HOUSTON, TX 77082
State of Incorp. DE
Fiscal Year End February 28
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2021
TTM
2/28/2021
2/29/2020
2/28/2019
2/28/2018
2/28/2017
2/29/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6001113
Cash and cash equivalents6001113
Prepaid expense11202128  
Other undisclosed current assets     10 
Total current assets:71202229113
Noncurrent Assets
Property, plant and equipment      1
Total noncurrent assets:      1
TOTAL ASSETS:71202229114
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14717220913744105
Accounts payable13361101422064
Accrued liabilities 14112108952441
Total current liabilities:14717220913744105
Noncurrent Liabilities
Total liabilities:14717220913744105
Stockholders' equity
Stockholders' equity attributable to parent5(46)(153)(187)(108)(33)(101)
Common stock131131131131131131131
Additional paid in capital125,542124,685123,374121,705120,146118,609117,036
Accumulated deficit(125,668)(124,862)(123,658)(122,023)(120,386)(118,774)(117,269)
Total stockholders' equity:5(46)(153)(187)(108)(33)(101)
TOTAL LIABILITIES AND EQUITY:71202229114

Income statement (P&L) ($ in thousands)

11/30/2021
TTM
2/28/2021
2/29/2020
2/28/2019
2/28/2018
2/28/2017
2/29/2016
Operating expenses(757)(1,302)(1,635)(1,638)(1,613)(1,505)(2,005)
Operating loss:(757)(1,302)(1,635)(1,638)(1,613)(1,505)(2,005)
Nonoperating income
(Other Nonoperating income)
 981 1  
Other undisclosed income from continuing operations before equity method investments, income taxes98      
Net loss available to common stockholders, diluted:(660)(1,204)(1,634)(1,638)(1,612)(1,505)(2,005)

Comprehensive Income ($ in thousands)

11/30/2021
TTM
2/28/2021
2/29/2020
2/28/2019
2/28/2018
2/28/2017
2/29/2016
Net loss:(660)(1,204)(1,634)(1,638)(1,612)(1,505)(2,005)
Comprehensive loss, net of tax, attributable to parent:(660)(1,204)(1,634)(1,638)(1,612)(1,505)(2,005)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: